Guardant Health to Participate in the BofA Securities 2020 Healthcare Conference

Rhea-AI Summary

Guardant Health, a leader in precision oncology, will participate in the BofA Securities Virtual Healthcare Conference on May 13, 2020, at 1:20 p.m. PT. The event can be accessed via a live webcast on their website.

The company focuses on enhancing cancer care through proprietary blood tests and analytics, including Guardant360 and GuardantOMNI for advanced cancer patients. Additionally, Guardant Health's LUNAR program targets early-stage cancer detection and treatment options.

REDWOOD CITY, Calif., May 06, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the upcoming BofA Securities Virtual Healthcare Conference.

Guardant Health’s management is scheduled for a fireside on Wednesday, May 13^th at 1:20 p.m. Pacific Time / 4:20 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360 and GuardantOMNI tests for advanced stage cancer patients. These tests fuel development of its LUNAR program, which aims to address the needs of early stage cancer patients with neoadjuvant and adjuvant treatment selection, cancer survivors with surveillance, asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.    

Investor Contact:
Carrie Mendivil
investors@guardanthealth.com

Media Contact:
Anna Czene
press@guardanthealth.com

FAQ

What is the date and time of Guardant Health's presentation at the BofA Securities Virtual Healthcare Conference?

Guardant Health's presentation is on May 13, 2020, at 1:20 p.m. Pacific Time.

How can I access Guardant Health's presentation at the conference?

You can access the live and archived webcast on Guardant Health's website under the 'Investors' section.

What is the main focus of Guardant Health according to the press release?

Guardant Health focuses on precision oncology, utilizing proprietary blood tests and advanced analytics to improve cancer care.

What products does Guardant Health offer for cancer patients?

Guardant Health offers liquid biopsy-based tests, including Guardant360 and GuardantOMNI, for advanced-stage cancer patients.

What is the goal of Guardant Health's LUNAR program?

The LUNAR program aims to support early-stage cancer detection and treatment selection for various patient groups.